首页> 外文期刊>Cancer biology & therapy >Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study
【24h】

Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study

机译:P53结合位点遗传变异与中国人群中骨肉瘤风险的关系:两阶段病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Osteosarcoma (OS) is one of the most common bone malignancies in children and adolescents. To date, inaugural mechanism of OS was considered as a complex process and was still not clear. The p53 gene, most important tumor suppressors, was associated with risk of many tumors, including OS. In current study, we evaluated the relationship between genetic variation of the p53 binding site and the OS susceptibility through a two-stage case-control study in Chinese population. We found that rs1295925 (OR = 0.85; 95 CI = 0.76-0.94; P = 0.003) and rs3787547 (OR = 1.27; 95 CI = 1.11-1.45; P = 4.0 x 10(-4)) was significantly with OS susceptibility. Compared with those with rs1295925-TT genotype, and the risk of OS was significantly lower in individuals with CT genotype (OR = 0.77; 95 CI = 0.65-0.92) and CC genotype (OR = 0.75; 95 CI = 0.60-0.93). Compared with those with rs3787547-GG genotype, and the risk of OS was significantly higher in individuals with AG genotype (OR = 1.32; 95 CI = 1.10-1.58) and AA genotype (OR = 1.46; 95 CI = 1.11-1.92). To sum up, our results prove that SNP rs1295925 and rs3787547 play an important role in the etiology of OS, suggesting them as the potential genetic modifier for OS development.
机译:骨肉瘤(OS)是儿童和青少年中最常见的骨质恶性肿瘤之一。迄今为止,OS的就职机制被认为是复杂的过程,仍然不明确。 P53基因,最重要的肿瘤抑制剂,与许多肿瘤的风险有关,包括OS。在目前的研究中,我们通过两阶段的中国人群进行了两阶段的病例对照研究,评估了P53结合位点的遗传变异与OS易感性之间的关系。我们发现RS1295925(或= 0.85; 95 CI = 0.76-0.94; P = 0.003)和RS3787547(或= 1.27; 95 CI = 1.11-1.45; P = 4.0×10(-4)显着与OS易感性显着。与RS1295925-TT基因型的基因型相比,具有CT基因型(或= 0.77; 95 CI = 0.65-0.92)和CC基因型(或= 0.75; 95 CI = 0.60-0.93)的个体中OS的风险显着降低。与RS3787547-GG基因型的基因型相比,Ag基因型(或= 1.32; 95 CI = 1.10-1.58)和AA基因型(或= 1.46; 95 CI = 1.11-1.92)的个体中os的风险显着高。总而言之,我们的结果证明SNP RS1295925和RS3787547在OS的病因中发挥着重要作用,表明它们是OS开发的潜在遗传改性剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号